Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Free Report) shares were down 8% during mid-day trading on Tuesday . The stock traded as low as $2.54 and last traded at $2.54. Approximately 1,250 shares were traded during mid-day trading, a decline of 37% from the average daily volume of 1,976 shares. The stock had previously closed at $2.76.
Mayne Pharma Group Price Performance
The business’s fifty day moving average is $2.83 and its 200 day moving average is $3.62.
Mayne Pharma Group Company Profile
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: International Branded Products, and Portfolio Product Division.
Featured Stories
- Five stocks we like better than Mayne Pharma Group
- Insider Buying Explained: What Investors Need to Know
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- What is a support level?
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- Investing in Travel Stocks Benefits
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
Receive News & Ratings for Mayne Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mayne Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.
